185 related articles for article (PubMed ID: 9044506)
1. Molecular pathology of posttransplantation lymphoproliferative disorders.
Chadburn A; Cesarman E; Knowles DM
Semin Diagn Pathol; 1997 Feb; 14(1):15-26. PubMed ID: 9044506
[TBL] [Abstract][Full Text] [Related]
2. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders.
Knowles DM; Cesarman E; Chadburn A; Frizzera G; Chen J; Rose EA; Michler RE
Blood; 1995 Jan; 85(2):552-65. PubMed ID: 7812011
[TBL] [Abstract][Full Text] [Related]
3. BCL-6 gene mutations in posttransplantation lymphoproliferative disorders predict response to therapy and clinical outcome.
Cesarman E; Chadburn A; Liu YF; Migliazza A; Dalla-Favera R; Knowles DM
Blood; 1998 Oct; 92(7):2294-302. PubMed ID: 9746767
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetic analysis demonstrates that multiple posttransplantation lymphoproliferative disorders occurring in one anatomic site in a single patient represent distinct primary lymphoid neoplasms.
Chadburn A; Cesarman E; Liu YF; Addonizio L; Hsu D; Michler RE; Knowles DM
Cancer; 1995 Jun; 75(11):2747-56. PubMed ID: 7743481
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus latent membrane protein-1 oncogene deletion in post-transplantation lymphoproliferative disorders.
Scheinfeld AG; Nador RG; Cesarman E; Chadburn A; Knowles DM
Am J Pathol; 1997 Sep; 151(3):805-12. PubMed ID: 9284829
[TBL] [Abstract][Full Text] [Related]
6. The morphologic and molecular genetic categories of posttransplantation lymphoproliferative disorders are clinically relevant.
Chadburn A; Chen JM; Hsu DT; Frizzera G; Cesarman E; Garrett TJ; Mears JG; Zangwill SD; Addonizio LJ; Michler RE; Knowles DM
Cancer; 1998 May; 82(10):1978-87. PubMed ID: 9587133
[TBL] [Abstract][Full Text] [Related]
7. Human immunodeficiency virus (HIV)-associated polymorphic lymphoproliferative disorders.
Nador RG; Chadburn A; Gundappa G; Cesarman E; Said JW; Knowles DM
Am J Surg Pathol; 2003 Mar; 27(3):293-302. PubMed ID: 12604885
[TBL] [Abstract][Full Text] [Related]
8. Post-transplantation lymphoproliferative disorders in Mexico: an aggressive clonal disease associated with Epstein-Barr virus type A.
Quintanilla-Martínez L; Lome-Maldonado C; Schwarzmann F; Gredler E; Reyes E; Angeles-Angeles A; Fend F
Mod Pathol; 1998 Feb; 11(2):200-8. PubMed ID: 9504692
[TBL] [Abstract][Full Text] [Related]
9. Posttransplantation lymphoproliferative disorders in bone marrow transplant recipients are aggressive diseases with a high incidence of adverse histologic and immunobiologic features.
Orazi A; Hromas RA; Neiman RS; Greiner TC; Lee CH; Rubin L; Haskins S; Heerema NA; Gharpure V; Abonour R; Srour EF; Cornetta K
Am J Clin Pathol; 1997 Apr; 107(4):419-29. PubMed ID: 9124210
[TBL] [Abstract][Full Text] [Related]
10. Plasmacytic hyperplasia in age-related Epstein-Barr virus-associated lymphoproliferative disorders: a report of two cases.
Kojima M; Morita Y; Nakamura N; Shimizu K; Murayama K; Nakamura S
Pathol Res Pract; 2008; 204(4):267-72. PubMed ID: 18187262
[TBL] [Abstract][Full Text] [Related]
11. Lymphoproliferative disease of donor origin arising in patients after orthotopic liver transplantation.
Armes JE; Angus P; Southey MC; Battaglia SE; Ross BC; Jones RM; Venter DJ
Cancer; 1994 Nov; 74(9):2436-41. PubMed ID: 7922997
[TBL] [Abstract][Full Text] [Related]
12. Immunodeficiency-associated lymphoproliferative disorders.
Knowles DM
Mod Pathol; 1999 Feb; 12(2):200-17. PubMed ID: 10071343
[TBL] [Abstract][Full Text] [Related]
13. Expression of p16/INK4a in posttransplantation lymphoproliferative disorders.
Martin A; Baran-Marzak F; El Mansouri S; Legendre C; Leblond V; Charlotte F; Davi F; Canioni D; Raphaël M
Am J Pathol; 2000 May; 156(5):1573-9. PubMed ID: 10793069
[TBL] [Abstract][Full Text] [Related]
14. Posttransplantation lymphoproliferative disorders frequently contain type A and not type B Epstein-Barr virus.
Frank D; Cesarman E; Liu YF; Michler RE; Knowles DM
Blood; 1995 Mar; 85(5):1396-403. PubMed ID: 7858270
[TBL] [Abstract][Full Text] [Related]
15. Recurrent Epstein-Barr virus-associated lesions in organ transplant recipients.
Wu TT; Swerdlow SH; Locker J; Bahler D; Randhawa P; Yunis EJ; Dickman PS; Nalesnik MA
Hum Pathol; 1996 Feb; 27(2):157-64. PubMed ID: 8617457
[TBL] [Abstract][Full Text] [Related]
16. Post-transplantation lymphoproliferative disorders arising in solid organ transplant recipients are usually of recipient origin.
Chadburn A; Suciu-Foca N; Cesarman E; Reed E; Michler RE; Knowles DM
Am J Pathol; 1995 Dec; 147(6):1862-70. PubMed ID: 7495309
[TBL] [Abstract][Full Text] [Related]
17. Detection of heterogeneous Epstein-Barr virus gene expression patterns within individual post-transplantation lymphoproliferative disorders.
Oudejans JJ; Jiwa M; van den Brule AJ; Grässer FA; Horstman A; Vos W; Kluin PM; van der Valk P; Walboomers JM; Meijer CJ
Am J Pathol; 1995 Oct; 147(4):923-33. PubMed ID: 7573368
[TBL] [Abstract][Full Text] [Related]
18. Disseminated, multiclonal Epstein-Barr virus-associated lymphoproliferative disease in a patient with hematological and immunological anomalies. Molecular analysis correlates with morphological appearance.
Armes JE; Eades S; Southey MC; Ross BC; Carapetis JR; Chow CW; Venter DJ
Diagn Mol Pathol; 1995 Mar; 4(1):39-47. PubMed ID: 7735554
[TBL] [Abstract][Full Text] [Related]
19. Hemophagocytic syndrome in Epstein-Barr virus-associated T-lymphoproliferative disorders: disease spectrum, pathogenesis, and management.
Su IJ; Wang CH; Cheng AL; Chen RL
Leuk Lymphoma; 1995 Nov; 19(5-6):401-6. PubMed ID: 8590839
[TBL] [Abstract][Full Text] [Related]
20. [The spectrum of lymphoproliferations and malignant lymphoma after organ transplant].
Müller-Hermelink HK; Ott G; Kneitz B; Rüdiger T
Verh Dtsch Ges Pathol; 2004; 88():63-8. PubMed ID: 16892535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
